All Stories

  1. The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition

    Article • Pharmacological Reviews, July 2012, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Tamara Bar-Magen Numhauser

  2. Transcription of Preintegrated HIV-1 cDNA Modulates Cell Surface Expression of Major Histocompatibility Complex Class I via Nef

    Article • Journal of Virology, January 2011, ASM Journals

    Tamara Bar-Magen Numhauser

  3. Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function

    Article • Journal of Antimicrobial Chemotherapy, September 2010, Oxford University Press (OUP)

    Tamara Bar-Magen Numhauser

  4. HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays

    Article • AIDS, September 2010, Wolters Kluwer Health

    Tamara Bar-Magen Numhauser

  5. Identification of a novel Achilles heel of HIV drug

    Article • Journal of Virology, July 2010, ASM Journals

    Tamara Bar-Magen Numhauser

  6. Neither ritonavir nor darunavir affect cell surface expression of tetherin or Vpu-mediated tetherin down-modulation

    Article • AIDS, July 2010, Wolters Kluwer Health

    Tamara Bar-Magen Numhauser

  7. The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity

    Article • Antimicrobial Agents and Chemotherapy, March 2010, ASM Journals

    Tamara Bar-Magen Numhauser

  8. At the forefront of retrovirology research: Frontiers of Retrovirology

    Article • HIV Therapy, January 2010, Future Medicine

    Tamara Bar-Magen Numhauser

  9. Tetherin restricts direct cell-to-cell infection of HIV-1

    Article • Retrovirology, January 2010, Springer Science + Business Media

    Tamara Bar-Magen Numhauser

  10. Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes

    Article • Retrovirology, January 2010, Springer Science + Business Media

    Tamara Bar-Magen Numhauser

  11. HIV entry blocked by maraviroc can cause an overestimation of viral load

    Article • Journal of the International AIDS Society, January 2010, Wiley

    Tamara Bar-Magen Numhauser

  12. Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1

    Article • Journal of the International AIDS Society, January 2010, Wiley

    Tamara Bar-Magen Numhauser

  13. Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture

    Article • Antimicrobial Agents and Chemotherapy, December 2009, ASM Journals

    Tamara Bar-Magen Numhauser

  14. Human Immunodeficiency Virus Type 1 Recombinant Reverse Transcriptase Enzymes Containing the G190A and Y181C Resistance Mutations Remain Sensitive to Etravirine

    Article • Antimicrobial Agents and Chemotherapy, August 2009, ASM Journals

    Tamara Bar-Magen Numhauser

  15. Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes

    Article • Retrovirology, January 2009, Springer Science + Business Media

    Tamara Bar-Magen Numhauser

  16. Comparative biochemical analysis of wildtype and drug resistant HIV-1 integrase subtypes B and C

    Article • Retrovirology, January 2009, Springer Science + Business Media

    Tamara Bar-Magen Numhauser

  17. Group A Human Rotavirus Genomics: Evidence that Gene Constellations Are Influenced by Viral Protein Interactions

    Article • Journal of Virology, September 2008, ASM Journals

    Tamara Bar-Magen Numhauser

  18. Novel activity of one of rotavirus proteins

    Article • Virology, December 2007, Elsevier

    Tamara Bar-Magen Numhauser